JPS6256152B2 - - Google Patents

Info

Publication number
JPS6256152B2
JPS6256152B2 JP56073777A JP7377781A JPS6256152B2 JP S6256152 B2 JPS6256152 B2 JP S6256152B2 JP 56073777 A JP56073777 A JP 56073777A JP 7377781 A JP7377781 A JP 7377781A JP S6256152 B2 JPS6256152 B2 JP S6256152B2
Authority
JP
Japan
Prior art keywords
acetic acid
compound
general formula
nax
thienyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP56073777A
Other languages
English (en)
Japanese (ja)
Other versions
JPS57188587A (en
Inventor
Kazuo Matsumoto
Koki Takashima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Priority to JP56073777A priority Critical patent/JPS57188587A/ja
Priority to EP82103636A priority patent/EP0065145B1/en
Priority to US06/372,990 priority patent/US4460596A/en
Publication of JPS57188587A publication Critical patent/JPS57188587A/ja
Publication of JPS6256152B2 publication Critical patent/JPS6256152B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP56073777A 1981-05-15 1981-05-15 Thienyloxazolylacetic acid derivative and its preparation Granted JPS57188587A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP56073777A JPS57188587A (en) 1981-05-15 1981-05-15 Thienyloxazolylacetic acid derivative and its preparation
EP82103636A EP0065145B1 (en) 1981-05-15 1982-04-28 Novel thienyloxazolylacetic acid derivatives and process for preparing same
US06/372,990 US4460596A (en) 1981-05-15 1982-04-29 Thienyloxazolylacetic acid derivatives and process for preparing

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56073777A JPS57188587A (en) 1981-05-15 1981-05-15 Thienyloxazolylacetic acid derivative and its preparation

Publications (2)

Publication Number Publication Date
JPS57188587A JPS57188587A (en) 1982-11-19
JPS6256152B2 true JPS6256152B2 (en:Method) 1987-11-24

Family

ID=13527966

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56073777A Granted JPS57188587A (en) 1981-05-15 1981-05-15 Thienyloxazolylacetic acid derivative and its preparation

Country Status (3)

Country Link
US (1) US4460596A (en:Method)
EP (1) EP0065145B1 (en:Method)
JP (1) JPS57188587A (en:Method)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58148882A (ja) * 1982-02-26 1983-09-05 Tanabe Seiyaku Co Ltd フリルオキサゾリル酢酸誘導体及びその製法
JPS58201771A (ja) * 1982-05-19 1983-11-24 Tanabe Seiyaku Co Ltd アルキルオキサゾリル酢酸誘導体
ZW19786A1 (en) * 1985-10-17 1988-05-18 Hoffmann La Roche Heterocyclic compounds
FR2730231B1 (fr) * 1995-02-02 1997-04-04 Fournier Sca Lab Association de fenofibrate et de vitamine e, utilisation en therapeutique
JP4073786B2 (ja) * 2001-04-16 2008-04-09 田辺三菱製薬株式会社 高コンダクタンス型カルシウム感受性ｋチャネル開口薬

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI53314C (fi) * 1967-06-14 1978-04-10 Wyeth John & Brother Ltd Foerfarande foer framstaellning av farmaceutiskt anvaendbar 2-(fenyleller p-klorfenyl) oxazol-4-yl (aettiksyra -acetatsalt eller -acetamid)
GB1245087A (en) * 1967-10-26 1971-09-02 Wyeth John & Brother Ltd Heterocyclic compounds
US3578671A (en) * 1967-11-06 1971-05-11 Wyeth John & Brother Ltd Oxazoles
AR208400A1 (es) * 1974-03-13 1976-12-27 Yoshitomi Pharmaceutical Un metodo para producir nuevos acidos 5-alcoxi-4-oxazolalcanoicos 2-substituidos y sus esteres

Also Published As

Publication number Publication date
JPS57188587A (en) 1982-11-19
EP0065145A1 (en) 1982-11-24
US4460596A (en) 1984-07-17
EP0065145B1 (en) 1984-10-03

Similar Documents

Publication Publication Date Title
JP3094453B2 (ja) チエノトリアゾロジアゼピン化合物およびその医薬用途
WO2021057872A1 (zh) 一种protac小分子化合物及其应用
KR20070004769A (ko) 대사 장애의 치료에 사용되는 화합물, 약제학적 조성물 및그 사용방법
CN102918034A (zh) 多取代芳族化合物作为凝血酶的抑制剂
JP2004517098A (ja) インドール誘導体
JPH0471073B2 (en:Method)
JP2001518090A (ja) 腫瘍壊死因子の阻害に有用な複素環により置換したヒドロキサム酸
KR900006118B1 (ko) 4-퀴놀론 유도체의 제법
JPS6256152B2 (en:Method)
EP0087782B1 (en) Furyloxazolylacetic acid derivatives, process for preparing same and pharmaceutical compositions containing same
JPH0433793B2 (en:Method)
CN106470981A (zh) 2‑[3‑氰基‑4‑异丁氧基苯基]‑4‑甲基噻唑‑5‑甲酸的新型衍生物、其制备方法和应用
JPH0827130A (ja) 新規な５−置換イソキサゾール−３−カルボン酸アミド誘導体
JP2005519042A (ja) 異脂肪血症状態を治療するための治療用化合物
US4535089A (en) Alkyloxazolylacetic acid derivative for the treatment of hyperlipidemia
CN112479921B (zh) 具有PPARδ激动活性的化合物、药物组合物及医药用途
KR900002658B1 (ko) 푸릴옥사졸일 아세트산 유도체의 제조방법
JPH0449B2 (en:Method)
JPS6331444B2 (en:Method)
EP0284069B1 (en) Benzopyranopyridineacetic acid ester compounds and their pharmaceutical uses
JPH064584B2 (ja) 新規アニリド誘導体
GB1572993A (en) Ester derivatives of cefuroxime
JPS58113183A (ja) 環状イミノカルボン酸誘導体およびその塩類
JPH0616663A (ja) テトラヒドロベンゾ〔ｂ〕チオフェン誘導体及びその製法
WO1981001553A1 (fr) Derives de l'acide oxalylacetique